Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Validation of a Preclinical Drug Screening Platform for Pharmacoresistant Epilepsy
Melissa Barker‐Haliski, Kristina Johnson, P. R. Billingsley, et al.
Neurochemical Research (2017) Vol. 42, Iss. 7, pp. 1904-1918
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs
Wolfgang Löscher
Neurochemical Research (2017) Vol. 42, Iss. 7, pp. 1873-1888
Closed Access | Times Cited: 314
Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models
Pabitra Hriday Patra, Melissa Barker‐Haliski, H. Steve White, et al.
Epilepsia (2018) Vol. 60, Iss. 2, pp. 303-314
Open Access | Times Cited: 137
Neuroinflammation in epileptogenesis: Insights and translational perspectives from new models of epilepsy
Melissa Barker‐Haliski, Wolfgang Löscher, H. Steve White, et al.
Epilepsia (2017) Vol. 58, Iss. S3, pp. 39-47
Open Access | Times Cited: 98
Single-Target Versus Multi-Target Drugs Versus Combinations of Drugs With Multiple Targets: Preclinical and Clinical Evidence for the Treatment or Prevention of Epilepsy
Wolfgang Löscher
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 84
Human pallial MGE-type GABAergic interneuron cell therapy for chronic focal epilepsy
Marina Bershteyn, Sonja Bröer, Mansi Parekh, et al.
Cell stem cell (2023) Vol. 30, Iss. 10, pp. 1331-1350.e11
Open Access | Times Cited: 33
The current approach of the Epilepsy Therapy Screening Program contract site for identifying improved therapies for the treatment of pharmacoresistant seizures in epilepsy
Karen S. Wilcox, Peter J. West, Cameron S. Metcalf
Neuropharmacology (2019) Vol. 166, pp. 107811-107811
Open Access | Times Cited: 70
Validated animal models for antiseizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screening
Melissa Barker‐Haliski, H. Steve White
Neuropharmacology (2019) Vol. 167, pp. 107750-107750
Open Access | Times Cited: 62
Alzheimer’s Disease and Epilepsy: A Perspective on the Opportunities for Overlapping Therapeutic Innovation
Leanne M Lehmann, Alexandria Lo, Kevin M. Knox, et al.
Neurochemical Research (2021) Vol. 46, Iss. 8, pp. 1895-1912
Open Access | Times Cited: 42
Inhibition of astroglial connexin43 hemichannels with TAT‐Gap19 exerts anticonvulsant effects in rodents
Laura Walrave, Anouk Pierre, Giulia Albertini, et al.
Glia (2018) Vol. 66, Iss. 8, pp. 1788-1804
Open Access | Times Cited: 54
Drug-resistant epilepsy: From multiple hypotheses to an integral explanation using preclinical resources
Daniel Pérez‐Pérez, Christian Lizette Frías‐Soria, Luísa Rocha
Epilepsy & Behavior (2019) Vol. 121, pp. 106430-106430
Closed Access | Times Cited: 44
Chronic seizures induce sex-specific cognitive deficits with loss of presenilin 2 function
Kevin M. Knox, Megan Beckman, Carole Smith, et al.
Experimental Neurology (2023) Vol. 361, pp. 114321-114321
Closed Access | Times Cited: 13
ENX‐101, a GABAA receptor α2,3,5‐selective positive allosteric modulator, displays antiseizure effects in rodent seizure and epilepsy models
Jordi Serrats, Krishna C. Vadodaria, William D. Brubaker, et al.
Epilepsia (2025)
Open Access
Target inhibition of NAT10-mediated ac4C modification prevents seizure behavior in mice
Angela Zhang, Jingwen Yang, Meng Wang, et al.
Neuropharmacology (2025), pp. 110415-110415
Closed Access
MK-212 precipitates seizure-induced death in amygdala-kindled mice via a non-5-HT2C receptor-mediated mechanism
Katelyn G. Joyal, Nicole A. Boodhoo, Gordon F. Buchanan
Epilepsy & Behavior (2025) Vol. 167, pp. 110385-110385
Closed Access
In vitro and in vivo experimental models employed in the discovery and development of antiepileptic drugs for pharmacoresistant epilepsy
Gonçalo Campos, Ana Fortuna, Amílcar Falcão, et al.
Epilepsy Research (2018) Vol. 146, pp. 63-86
Closed Access | Times Cited: 43
Lamotrigine-resistant corneal-kindled mice: A model of pharmacoresistant partial epilepsy for moderate-throughput drug discovery
Zachery Koneval, Kevin M. Knox, H. Steve White, et al.
Epilepsia (2018) Vol. 59, Iss. 6, pp. 1245-1256
Open Access | Times Cited: 40
Higher susceptibility to 6 Hz corneal kindling and lower responsiveness to antiseizure drugs in mouse models of Alzheimer's disease
Maxime Vande Vyver, Melissa Barker‐Haliski, Najat Aourz, et al.
Epilepsia (2022) Vol. 63, Iss. 10, pp. 2703-2715
Open Access | Times Cited: 19
Development of Antiepileptic Drugs throughout History: From Serendipity to Artificial Intelligence
María Gabriela Corrales-Hernández, Sebastián Kurt Villarroel-Hagemann, Isabella Mendoza-Rodelo, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1632-1632
Open Access | Times Cited: 12
A companion to the preclinical common data elements for pharmacologic studies in animal models of seizures and epilepsy. A Report of the TASK3 Pharmacology Working Group of the ILAE/AES Joint Translational Task Force
Melissa Barker‐Haliski, Lauren C. Harte‐Hargrove, Teresa Ravizza, et al.
Epilepsia Open (2018) Vol. 3, Iss. S1, pp. 53-68
Open Access | Times Cited: 34
Stereoselective Analysis of the Antiseizure Activity of Fenfluramine and Norfenfluramine in Mice: Is l-Norfenfluramine a Better Follow-Up Compound to Racemic-Fenfluramine?
Natalia Erenburg, Emilio Perucca, Jeff Bechard, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2522-2522
Open Access | Times Cited: 3
Innovative drug discovery strategies in epilepsy: integrating next-generation syndrome-specific mouse models to address pharmacoresistance and epileptogenesis
Melissa Barker‐Haliski, Nicole A. Hawkins
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 9, pp. 1099-1113
Closed Access | Times Cited: 3
Evaluation of Selective 5-HT2C Agonists in Acute Seizure Models
Leonardo B. Silenieks, Nicole K. Carroll, Annalise Van Niekerk, et al.
ACS Chemical Neuroscience (2019) Vol. 10, Iss. 7, pp. 3284-3295
Closed Access | Times Cited: 27
Evaluation of antiseizure drug efficacy and tolerability in the rat lamotrigine‐resistant amygdala kindling model
Cameron S. Metcalf, Jennifer Huff, Kyle Thomson, et al.
Epilepsia Open (2019) Vol. 4, Iss. 3, pp. 452-463
Open Access | Times Cited: 27
Recurrent epileptiform discharges in the medial entorhinal cortex of kainate‐treated rats are differentially sensitive to antiseizure drugs
Peter J. West, Gerald W. Saunders, P. R. Billingsley, et al.
Epilepsia (2018) Vol. 59, Iss. 11, pp. 2035-2048
Open Access | Times Cited: 25
Zebrafish-Based Discovery of Antiseizure Compounds from the North Sea: Isoquinoline Alkaloids TMC-120A and TMC-120B
Daniëlle Copmans, Sara Kildgaard, Silas Anselm Rasmussen, et al.
Marine Drugs (2019) Vol. 17, Iss. 11, pp. 607-607
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top